Cargando…

Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair

Detalles Bibliográficos
Autores principales: Zhou, Jianli, Sturtevant, Drew, Love, Cassie, Kulkarni, Aditya, Biyani, Neha, Kathad, Umesh, Thacker, Elizabeth, Dave, Sandeep, Bhatia, Kishor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360926/
https://www.ncbi.nlm.nih.gov/pubmed/37477520
http://dx.doi.org/10.18632/oncotarget.28479
_version_ 1785076120967708672
author Zhou, Jianli
Sturtevant, Drew
Love, Cassie
Kulkarni, Aditya
Biyani, Neha
Kathad, Umesh
Thacker, Elizabeth
Dave, Sandeep
Bhatia, Kishor
author_facet Zhou, Jianli
Sturtevant, Drew
Love, Cassie
Kulkarni, Aditya
Biyani, Neha
Kathad, Umesh
Thacker, Elizabeth
Dave, Sandeep
Bhatia, Kishor
author_sort Zhou, Jianli
collection PubMed
description
format Online
Article
Text
id pubmed-10360926
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-103609262023-07-22 Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair Zhou, Jianli Sturtevant, Drew Love, Cassie Kulkarni, Aditya Biyani, Neha Kathad, Umesh Thacker, Elizabeth Dave, Sandeep Bhatia, Kishor Oncotarget Addendum Impact Journals LLC 2023-07-20 /pmc/articles/PMC10360926/ /pubmed/37477520 http://dx.doi.org/10.18632/oncotarget.28479 Text en Copyright: © 2023 Zhou et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Addendum
Zhou, Jianli
Sturtevant, Drew
Love, Cassie
Kulkarni, Aditya
Biyani, Neha
Kathad, Umesh
Thacker, Elizabeth
Dave, Sandeep
Bhatia, Kishor
Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair
title Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair
title_full Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair
title_fullStr Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair
title_full_unstemmed Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair
title_short Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair
title_sort addendum: lp-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-hodgkin’s lymphoma models and in cells deficient in dna damage repair
topic Addendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360926/
https://www.ncbi.nlm.nih.gov/pubmed/37477520
http://dx.doi.org/10.18632/oncotarget.28479
work_keys_str_mv AT zhoujianli addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair
AT sturtevantdrew addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair
AT lovecassie addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair
AT kulkarniaditya addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair
AT biyanineha addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair
AT kathadumesh addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair
AT thackerelizabeth addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair
AT davesandeep addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair
AT bhatiakishor addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair